Latest Financial Results
Q2 2026
Quarter Ended Jun 30, 2026
Latest News
Latest Presentation
Investor Presentation View PresentationCompany Overview
SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas.
Email Alerts
Sign up today and receive company updates straight to your inbox.
Contact Us
Company
SCYNEXIS, Inc.
1 Evertrust Plaza
13th Floor
Jersey City, NJ 07302
T: (201) 884-5485
info@scynexis.com
Investor Relations
LifeSci Advisors
John Fraunces
T: 917-355-2395
jfraunces@lifesciadvisors.com
Transfer Agent
American Stock Transfer & Trust Company, LLC
10150 Mallard Creek Road
Suite 307
Charlotte, NC 28262
T: 800-937-5449